Literature DB >> 2731171

Hyaluronic acid-stimulating activity in sera from the bovine fetus and from breast cancer patients.

M Decker1, E S Chiu, C Dollbaum, A Moiin, J Hall, R Spendlove, M T Longaker, R Stern.   

Abstract

The sine qua non of malignancy is the ability of tumor cells to migrate and invade surrounding tissue. There are many substances that have been described that enhance cell motility and hyaluronic acid is prominent among these. Hyaluronic acid is a high molecular weight alternating disaccharide polymer found in abundance in extracellular matrices whenever rapid cell proliferation or tissue regeneration and repair occur. It creates a permissive environment for cell motility during embryogenesis, and high levels of hyaluronic acid also correlate with increased tumor cell invasion and aggressiveness. Little is known about the regulation of hyaluronic acid production, either in normal tissue or in malignancy. In this study, we characterize a hyaluronic acid-stimulating activity in fetal calf serum and describe a similar activity in the sera of breast cancer patients. The stimulating activity was measured by placing aliquots of test substance on fibrosarcoma cells. These indicator cells, which synthesize copious quantities of hyaluronic acid, respond to stimulation in a time- and dose-dependent fashion. The fetal calf serum hyaluronic acid-stimulating activity is maximum early in gestation and then falls rapidly to essentially no activity at term. This activity was partially purified from 120-day fetal calf serum by concanavalin A-Sepharose affinity and ion exchange chromatography and is accounted for by a glycoprotein with a molecular weight of 150,000 on gel filtration under native conditions. The sera of breast cancer patients with measurable burden of disease also contained hyaluronic acid-stimulating activity, which was not present in normal serum donors or in breast cancer patients without evidence of disease. The production of this stimulating activity may contribute to the development of the malignant phenotype by inducing hyaluronic acid-rich microenvironments that are permissive to tumor cell invasion and metastases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731171

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid.

Authors:  M T Longaker; E S Chiu; N S Adzick; M Stern; M R Harrison; R Stern
Journal:  Ann Surg       Date:  1991-04       Impact factor: 12.969

2.  Hyaluronic acid in a cardiac myxoma: a biochemical and histological analysis.

Authors:  M T Longaker; E S Chiu; B Hendin; W E Finkbeiner; R Stern
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Scarless fetal healing. Therapeutic implications.

Authors:  N S Adzick; M T Longaker
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

Review 4.  Scarless skin wound repair in the fetus.

Authors:  H P Lorenz; N S Adzick
Journal:  West J Med       Date:  1993-09

5.  Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells.

Authors:  T K Yeo; J A Nagy; K T Yeo; H F Dvorak; B P Toole
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma.

Authors:  T Spruss; G Bernhardt; H Schönenberger; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Prostaglandin E2 stimulates cyclic AMP-mediated hyaluronan synthesis in rabbit pericardial mesothelial cells.

Authors:  A Honda; Y Sekiguchi; Y Mori
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

8.  Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo.

Authors:  K Beckenlehner; S Bannke; T Spruss; G Bernhardt; H Schönenberg; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells.

Authors:  E A Turley; L Austen; K Vandeligt; C Clary
Journal:  J Cell Biol       Date:  1991-03       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.